pVerify vs Tennr
Two Patient Access & Intake vendors, side by side. Facts from public sources; judgments are ours.
At a glance
Derived from public facts · a rough scale, not a ranking
| pVerify | Tennr | |
|---|---|---|
| Pricing model | Per-transaction / per-chart · Per-check API pricing, volume tiers | Not published · enterprise pricing by workflow and volume |
| Speed to go live | API keys in days; portal is self-serve | Typical 2-3 month implementation |
| Automation model | Software platform · API and portal, no services layer | Software platform · Document AI with human review queues |
| Built for | Small practices, Mid-size groups, Billing companies | Small practices, Mid-size groups |
| Security posture | SOC 2 Type II, HIPAA | SOC 2 Type II, HIPAA |
| Company maturity | 20 yrs (est. 2006) | 5 yrs (est. 2021) |
| Financial backing | Acquired by DoseSpot (2023) | $160M+ · Series C |
| Named customers | None public | 5 named |
| Published results | No public numbers | Specific numbers public |
| Documented integrations | 4 listed | 4 listed |
| Third-party validation | KLAS / analyst cited | None found |
Bottom line
- Pick pVerify if you want to embed accurate, specialty-aware eligibility checks into your own software or intake workflow through an API rather than buy a full RCM platform.
- Pick Tennr if fax-heavy referral intake is your bottleneck and you want it automated without touching your EHR.
pVerify
REST APIs for real-time eligibility and benefits verification
- Founded
- 2006
- HQ
- Tustin, CA
- Stage
- Acquired by DoseSpot (2023)
- Raised
- n/a
What it does
- Real-time eligibility checks across 1,500+ payers
- Specialty-specific benefits parsing (vision, DME, therapy)
- Insurance discovery for unknown or inactive coverage
- Patient estimation and Medicare-specific checks (MBI lookup)
- Claim status and prior authorization support APIs
- Batch eligibility for appointment-day sweeps
Where it's strong
- Developer-first: well-documented APIs make it quick to embed eligibility into your own product.
- Specialty benefit parsing goes deeper than raw 270/271 responses from clearinghouses.
- Now part of PSG-backed DoseSpot, which adds financial stability and a bigger product family.
What buyers should weigh
- It solves front-end verification only; you still need separate tools for claims and denials.
- Named enterprise customer references are thin in public materials.
- Ongoing DoseSpot and Arrive Health consolidation (Interra Health) could shift roadmap priorities.
Integrations
Tennr
AI that reads faxed referrals and moves them to booked visits
- Founded
- 2021
- HQ
- New York, NY
- Stage
- Series C
- Raised
- $160M+
What it does
- Reads faxed referrals and extracts structured patient data
- Proprietary RaeLM models trained on 100M healthcare documents
- Qualifies patients against payer documentation criteria automatically
- Runs eligibility and benefits checks on incoming referrals
- Routes orders and populates downstream intake systems
- Tennr Network gives referrers and patients live referral status
Where it's strong
- Best-in-class at the ugly problem of fax and document-based referral intake, processing 10 million documents a month.
- Purpose-built models check documentation against payer criteria upfront, which cuts denials rather than just speeding data entry.
- Heavy funding ($101M Series C at a $605M valuation) and tripling revenue suggest it will keep shipping fast.
What buyers should weigh
- Strongest in referral-driven businesses like HME/DME, imaging, labs, and infusion; less relevant if referrals are not your bottleneck.
- Still a young company scaling quickly, so implementation attention may vary as the customer base grows.
- Pricing is volume-based on document throughput, which buyers should model carefully against current intake costs.
- Plan for a 2-3 month implementation and roughly a year to full ROI.
Named customers
Rothman Orthopaedics · Talkiatry · TwelveStone Health Partners · Performance Home Medical · BetterNight
Integrations
Compare against the rest of Patient Access & Intake
Deciding between these two?
First Pass tracks Patient Access & Intake every week: funding, launches, and what changed since this page was written.